Abstract

Psychedelic-assisted therapy (PAT) has gained attention for its potential in treating mental health conditions such as post-traumatic stress disorder (PTSD), depression, and anxiety, particularly in military populations. As evidence continues to demonstrate the efficacy of psychedelics like MDMA and psilocybin, there is a growing interest in their therapeutic use among active-duty personnel and veterans. However, the implementation of PAT in military clinical settings raises critical ethical concerns. Issues surrounding informed consent, potential coercion, equitable access, long-term safety, and alignment with military culture must be carefully examined. This paper explores these ethical considerations, emphasizing the importance of establishing a robust ethical framework to ensure the responsible and effective integration of PAT into military mental health care.